A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i (Q88122757)
Jump to navigation
Jump to search
scientific article published on 18 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i |
scientific article published on 18 June 2014 |
Statements
A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase (English)
Milan Petakov
Pilar Giraldo
Hanna Rosenbaum
Jeffrey Szer
Patrick B Deegan
Dominick J Amato
Eugen Mengel
Ee Shien Tan
Raul Chertkoff
Einat Brill-Almon